can be exploited by using cold enrichment for selective bacterial reproduction in faeces samples. Yersinia bacteria can also grow in refrigerated materials such as RBC concentrates -the main subject of this article -and can attain high levels if kept for long enough (see below). Many bacteria have specific mechanisms for absorbing iron from their environment. Detailed studies have been made of the different ways in which the various Y. enterocolitica serotypes are able to absorb the iron ions they require for growth [4] . Some Yersinia bacteria are capable of covering their requirements of approximately 10 -6 M iron from the extremely low concentration of approximately 10 -15 M free iron occurring in plasma. The extremely low concentration of free iron is attributable to intraplasmatic and extraplasmatic proteins such as transferrin, lactoferrin and ferritin, which have a high affinity for (trivalent) iron ions. These comprehensive activities performed by the host organism are believed to be a defensive mechanism against pathogens penetrating the tissue and blood stream. The system used by Y. enterocolitica, on the other hand, consists of two components when complete: siderophores and siderophore receptors. The siderophores are released by the bacteria into the environment where, as complex-forming molecules (< 1 kDa), they compete with the iron-binding proteins of the host organism to bind iron ions (Fe 3+ ). The iron-siderophore complexes produced in this manner are transported into the cell interior by siderophore receptors located on the surface of the bacteria [5] . Not all Y. enterocolitica strains have both components. Haemolytic anaemia and repeated transfusions increase the blood's content of haemoglobin released by the decomposing RBCs. Like the siderophores, the haemin set free from the haemoglobin can be absorbed by the receptors of Y. enterocolitica; in this manner, the bacteria gain access to a source of iron despite their lack of siderophores [4] . Other factors that are significant to the virulence of Yersinia bacteria have been described in addition to those determining iron absorption. These factors have chromosomal and plasmid encoding. The plasmid-encoded factors are almost exclusively expressed at 37 °C. The 70 kb large plasmid is easily lost during in vitro reproduction at temperatures above 30 °C. For this reason, any in vitro experiments into the strains involved must explicitly include determination of the presence of this plasmid; in addition, the starting temperature at which the strains are kept immediately before the experiment must be recorded as it is an important condition for the experiment. Some of the chromosomal virulence factors are deactivated at 37 °C while others become activated at this temperature. Table 1 contains a list of the main pathogenicity factors and their temperature-dependent functions. The different structures formed by the LPS depending on the temperature have the following effect: The rough, short-chain structure formed at 37 °C remains integrated in the cell membrane. The smooth, long-chain structure formed at ≤ 25 °C can detach itself from the membrane and become active as a free endotoxin. This is one reason why the symptoms typical of Gram-negative sepsis are absent in transient Yersinia infections (at a body temperature of 37 °C) with relatively low bacteria counts. However, when the bacteria reproduce in RBCs at low storage temperatures of approximately 4 °C, they produce a high concentration of free, long-chain LPS which induces the full clinical picture of acute, potentially fatal endotoxin shock in the transfusion recipient (oral report, J. Heesemann). The factors controlled by the plasmid allow the bacteria to overcome the non-specific immune response of the host organism at 37 °C. This can be seen in the reduced complement activity via the 'alternative way' (increased serum resistance), the resistance to phagocytosis and the decreased intracellular destruction of bacteria by macrophages. Only the infectiontriggered specific immune response eliminates the bacteria. It has been speculated that Y. enterocolitica penetrated into long-lived cells are capable of persisting in the body for extended periods of time, thus causing otherwise 'unexplained' bacteraemia [6] .
Reproduction of Y. enterocolitica in RBC Concentrates
Y. enterocolitica had attained a bacterial count of 10 8 -10 9 /ml in RBC concentrates which caused septicaemia although they were stored in accordance with regulations. It is currently believed that the bacteria in these RBCs are initially present at a level of 10-100 CFU(colony-forming units)/ml as brought about by an unidentified bacteraemia in the donor. It is only after 2-3 weeks that the bacteria begin to rapidly reproduce. The processes underlying this occurrence have not yet been fully explained. However, it appears that the specific characteristics of Y. enterocolitica and, in particular those of serotypes O:3, O:9 etc., combine to produce high bacterial counts in the contaminated RBCs [7] . How the processes involved in the production and storage of RBC concentrates [9] and is compatible with the high degree of O:3 serotype involvement in sepsis cases associated with transfusions.
Infection and Infectious Diseases
The clinical spectrum of infections caused by human-pathogenic Y. enterocolitica mainly comprises: -gastrointestinal disorders: enterocolitis or pseudoappendicitis, -septicaemia: primarily in immune-compromised patients and individuals suffering from hyperferraemia receiving treatment with deferoxamine or transfusion associated (see 3.
3), -metastatic colonisation with abscess development or local disease in the skin, lungs, endocardium etc. after septicaemia,
-post-infection complications (sequelae) such as those occurring as a consequence of other bacterial infections like arthritis, myocarditis, glomerulonephritis, erythema nodosum (in this case restricted to carriers of the HLA-B27 antigen). In the case of peroral infections, bacteria can colonise the ileocolic region and cause ulcers there, frequently accompanied by transient bacteraemia. The ulcers then either heal spontaneously or take a septicaemic course. In infants, infection with Yersinia bacteria can develop into severe enterocolitis, which may become life-threatening. Rectal haemorrhage and intestinal perforation can occur. The standard symptoms of enterocolitis in older children or adults are diarrhoea, fever and abdominal pain centred on the lower right quadrant of the abdomen, accompanied by symptoms resembling appendicitis and triggered by inflammation of the local lymph nodes. However, these symptoms may be only mildly expressed or even absent. In a clinical context, the symptoms in adults are difficult to distinguish from those occurring in a multitude of other banal gastrointestinal infections. Microbiological diagnosis is rarely initiated on the strength of these symptoms. Excretion of the pathogen in the faeces can continue after all symptoms have receded (2-6 weeks) [10] . Whether the bacteria can persist after this time in tissue is still a matter of discussion [6] .
Epidemiology
Y. enterocolitica is prevalent worldwide, but is more common in temperate to cool climate zones. Serotypes O:3 and O:9 are most widespread in (Northern) Europe while serotypes O:3 and O:8 are most common in North America. Serotype O:3, which was initially restricted to Europe, has recently spread to the North American continent. Serotype O:8, which is regarded as being particularly virulent, has not been identified in Germany to date but has been isolated in the Netherlands. Pathogenic Y. enterocolitica strains are found in water supplies and animals, in Germany particularly in domestic pigs. Infections originate from foodstuffs such as milk and dairy products as well as pork [1] , especially offal. Investigations into infections usually show that the foodstuffs were not sufficiently heated during cooking. A large proportion of asymptomatically infected persons is likely in the event of an outbreak of infection [11] . Nosocomial outbreaks with transmission of the infection from patient to patient have been reported [4] . A significant factor in regard to foodstuffs is the fact that, similarly to Listeria bacteria, refrigeration does not provide adequate protection against bacterial growth. Infections are most likely to occur in the winter months.
Detection Methods and their Significance
Yersinia bacteria are isolated from faeces, from intestinal biopsies or material collected during operations, from blood and on occasion from material from infected foci, using the primary selective culture media used for isolating other Entero-bacteriaceae. The more specific CIN and VYE culture media ensure an extremely high recovery rate and endow the colonies with a very characteristic appearance. However, primary use of these media is usually restricted to cases in which the laboratory is provided with suitable evidence of an infection with Yersinia bacteria. Cold enrichment has been used for many years; however, it entails a long procedure compared with culturing at 37 °C or 25 °C. At 0-4 °C, Yersinia bacteria have a considerable growth advantage over many other accompanying bacteria, some of which cannot reproduce at all at these temperatures. In addition to Y. enterocolitica, cold enrichment is frequently conducive to the growth of other Yersinia bacteria that are generally regarded as being harmless, such as Yersinia frederiksenii, Yersinia intermedia, Yersinia kristensenii and other psychrophilic bacteria. Serotype determination involves agglutination of the isolate with specific antisera. Antibody detection measures are more commonly used in epidemiological investigations (outbreak analyses) and in suspected post-infection disorders such as arthritis or myocarditis. Use of antibody detection in blood donor screening is of doubtful value, not to mention the associated costs. Single serological tests are currently unsuitable for the detection of fresh infections. In addition, there is a marked discrepancy between the extremely low rate of infections from RBC concentrates containing Yersinia bacteria and the reported frequency of positive serological reactions. Heesemann and Karch [10] reported that the use of universal (i.e. serotype-independent) Yersinia antigens in blood donors led to up to 40% of them being identified as solely IgG positive and up to 9% as solely IgA positive. A donor's increasing antibody titre in the period after blood donation can be interpreted as a sign of a freshly acquired infection and as evidence of a bacterial phase at the time of donation. However, interpretations of this kind must be regarded with great circumspection as experience with transfusion incidents caused by Yersinia bacteria is extremely limited.
Blood and Plasma Donors

Prevalence and Incidence in Donor Populations
No studies on the incidence of Y. enterocolitica in the faeces of blood donors are known to exist. There is also no known prospective study on the incidence of bacteraemia as made evident by expired RBCs examined for bacteria. Heeseman and Karch [10] , however, report on the incidence of donors with elevated Y. enterocolitica antibody titres. According to the study, 40% of them were identified as solely IgG positive, and up to 9% as solely IgA positive, (see 1.4) . A Finnish study [12] in which less specific antigen preparations were used (see 1.4), identified an incidence of up to 4% of the general populace in 'normal' people (prior exclusion of reactive arthritis and similar afflictions).
Definition of Exclusion Criteria
Routine testing of donors or donated blood for bacteria in general and Y. enterocolitica in particular is not carried out as no practical test method exists. Bacteraemia with few or no symptoms in the donor can thus go undetected. Antibody detection does not seem practical either. Identification of a fresh infection is dependent on an increase in specific IgG (see 1.4) . A minimum of two consecutive serological examinations of a blood donation would be necessary. Genome identification procedures (gene probes, nucleic acid amplification procedures) are not currently suited to this kind of routine use. There are periodic reports of individual examinations using other procedures.
Donor Testing and Significance
In a study conducted by the American Red Cross [13] , approximately 11,000 prospective blood donors were asked whether they had suffered from diarrhoea alone or diarrhoea accompanied by unusually severe abdominal pain and fever within the previous 4 weeks. 0.6% admitted to having suffered from the latter, whereas 4% admitted having suffered from diarrhoea alone. It was thus concluded that surveys are a relatively unspecific and inexact means of preventing transfusionassociated transmission of Y. enterocolitica. A blood donation service run by the German Red Cross determined the rate of donor rejection due to diarrhoea in 335,794 prospective donors. Donors who entered on the survey form that they had suffered from diarrhoea within the past 4 weeks were questioned extensively according to specified rules, and a doctor's decision was then made. As a result of this procedure, 221 people were deferred, a share of 0.066%. This rate of rejection was classified as not critical to blood supplies. In Canada there were reports of an attempt to discover bacteraemia which had gone undetected at the time of the blood donation by asking the donors to report the occurrence of diarrhoea or infection in the week following donation. In this way, approximately 0.03% of the donors prompted a post-examination of the donation and, in some cases, subsequent follow-up into the transfusion recipients. In no case, bacteria could be identified or transfusion incidents traced [14] . In order to prevent the transmission of Y. enterocolitica, those undertaking an autotransfusion are advised to observe the same stringent criteria that apply to foreign blood transfusions.
Donor Interviews
In the event that a transfusion incident is traced to Y. enterocolitica, the donor is usually questioned intensively to explain the epidemiological connection. If necessary, he/she is asked to undergo a follow-up examination to search for the pathogen in faecal samples or check serological or other parameters for a freshly acquired Yersinia infection. For the donor, the event is usually of no further consequence, since this pathogen is likely to have been only subject of a transitory bacteraemia. Occasionally, the findings can shed light on previously unexplained joint disorders.
Recipients
Prevalence and Incidence of Blood-Associated Infections and Infectious Diseases in Recipient Populations
In the USA, 11 cases of Yersinia sepsis were reported to the authorities in connection with the transfusion of RBC concentrates between 1985 and 1991. Between 1991 and 1996, there were 10 such cases [8] . 50% of sepsis cases triggered by RBC concentrates in the USA were traced to Y. enterocolitica [15] . [17] , based on figures reported to the US Food and Drug Administration (FDA). However, it is not known how many of the transfusion incidents resulting in death are actually reported to the FDA. It is possible that a more systematically conducted bacterial examination of less serious transfusion incidents would also provide a more exact picture of the situation. The transmission of Yersinia through pooled platelet concentrates has been reported twice to date [16, 18] . It is interesting to note that in several of the reported cases, the transfusion of platelet concentrates passed without incident while RBC concentrates from the same donation caused Yersinia sepsis resulting in death [19] [20] [21] . No summarised figures over a similar time period exist for Germany. Case reports of incidents have been published, however [22] ; one report to the Paul-Ehrlich-Institut also exists. Yersinia sepsis cases have also been reported repeatedly in connection with autologous blood donations [23, 24] . One marked feature of the Y. enterocolitica transfusion incidents occurring world-wide was that only strains which were not characterised by siderophore development were identified, namely the serotypes O:3, O:9, O:5,27, etc. (see the lists in [4, 7, 21] ). The siderophore-producing serotype O:8, which is relatively common in the USA and generally viewed as virulent, has so far not been observed in transfusion incidents there, either (see 1.1). The existing evidence suggests that transfusion incidents linked to Y. enterocolitica were considerably less common before 1985 than in the years after. In the search for relevant changes appearing in the mid-1980s which might explain the increased number of incidents, Gibb et al. [25] concentrated on the introduction of the additive preservative solution for RBCs. In the USA, for example, this solution was introduced between 1983 and 1985. The additive solution replaces up to 90% of the plasma which was used before. Gibb et al. [25] showed that complement-sensitive Y. enterocolitica is not killed in plasma concentrations lower than 25%, which is not the case with 100% plasma. Accordingly, it should be investigated whether the time elapsing between the donation and the separation of the components was shortened in those years as well. This would reduce the length of time remaining for the complement to take effect before the plasma is replaced. Gibb et al. [25] raise a third possibility, namely that the incidence of Y. enterocolitica infections in the general populace might have increased during the 1980s. There is no evidence of this world-wide. It is interesting to note that no noticeable changes in transfusion incident statistics were reported in Belgium, where there was a 6-fold decrease [1] in isolated cases of Y. enterocolitica in the general populace from the mid-1980s to 1996. In New Zealand, however, epidemiological studies of the total population have been carried out [21] . Between 1991 and 1996, 8 Y. enterocolitica-related transfusion incidents (5 of them with fatal outcome) were observed, corresponding to an incidence of 1:65,000.
Immune Status (Resistance, Existing Immunity, Immune Response, Age, Exogenous Factors)
Transfusion of blood which is heavily contaminated with bacteria is always life-threatening. The bacteria can reach a concentration of 10 9 /ml. Even more serious in nature is the concentration of endotoxins which are released when the bacteria multiply. Concentrations of 600 ng/ml have been measured repeatedly in transfused RBC concentrates. Endotoxin amounts of ≥ 1 ng/kg body weight are sufficient to trigger a feverish reaction [26] . Just a few millilitres of donated blood can thus be sufficient to cause a life-threatening situation for the patient. This also corresponds to the clinical course documented in case reports. Neither the specific immune response (which may develop following infection with Y. enterocolitica) nor the unspecific response offer protection against the flooding of the bloodstream with bacteria and endotoxins. In the event of exposure, one must assume that any existing specific antibodies would be depleted within a short period of time. The booster reaction, which takes several days to take effect, is useless in the acute event. In the presence of low bacterial and endotoxin concentrations, the severity of the shock symptoms can depend on the patient's general condition, including age. No studies on this subject are available.
Severity and Course of the Disease
Of the 10 Y. enterocolitica-related incidents reported in the USA between 1991 and 1996, 5 of the patients died within 6 days of receiving the transfusion. The transfusion of blood contaminated with Y. enterocolitica triggers the symptoms typical of endotoxin shock, such as circulatory collapse, fever, respiratory distress (ARDS) and disseminated intravasal coagulation (DIC). When transfusions are carried out with lower levels of contamination, symptoms can be limited to hypotonia and raised temperatures. In the case of fatal outcome de-spite intensive medical care, the cause of death is usually multiple organ failure. If a patient receives a transfusion with contaminated blood while anaesthetised, the first signs of the endotoxin effect (elevated temperature and decreased blood pressure) can be occult or very discrete.
Therapy and Prophylaxis
Antibiotics do not help against the acute effects of Yersinia sepsis. Patients require immediate intensive medical care to combat endotoxin shock. At this time, however, the multiplication of the infused pathogenic organisms (which are generally not yet identified) must be prevented through broad-spectrum antibiotic cover. The extent to which the decomposing bacteria may release further endotoxins has not yet been discussed in detail in the literature [27] . In order to identify the pathogen, a blood culture should be prepared before the antibiotics are administered (as in any transfusion incident, in general). This is not always possible in practice as the patient may already have been treated with antibiotics for other indications. Even in this event, however, a blood culture should be set up and the reason for antibiotic administration should be noted, along with the name of the drug, when the examination material is passed on. The apertures of the blood bag must be sterilised and sealed, and the bag must be forwarded immediately to the issuing blood bank as this is where the necessary measures, including microbiological examinations, have to be arranged. It is advisable to undertake a bacterial count and pyrogen identification in addition to the customary microbiological diagnosis. There are no known direct prophylactic measures to counteract the effects of contaminated blood. Antibiotic prophylaxis alone is not indicated since this is ineffective against endotoxin shock, as stated above. However, there are no doubt many cases in which transfusions occur during antibiotic treatment since this may be required owing to the underlying disease or perioperative conditions. Metastatic foci (see 1.2) may develop subsequent to sepsis. This danger must be averted where necessary by antibiotic therapy of sufficiently long duration.
Transmissibility
According to the current status of knowledge, there is no danger to a patient's immediate environment after he has recovered from Yersinia sepsis. The extent to which a patient can be expected to persistently excrete the bacteria following recovery, and whether this can result in health risks for the patient or his environment, is not known. See section 1.2 for information on the late complications of infection with Y. enterocolitica, such as arthritis.
Frequency of Administration, Type and Amount of Blood Products
Contamination with Y. enterocolitica occurs only with RBC concentrates and, to a much lesser extent, with platelet concentrates. It makes no difference whether the transfusion involves the patient's own or foreign blood. The risk of RBC concentrates being contaminated can be conservatively estimated at 1:500,000 (see further estimates in 3.1). Mass transmission of Y. enterocolitica is not to be expected with fresh frozen plasma or plasma derivatives.
Blood Products
Infectious Load of the Starting Material and Test Methods
The concentration of bacteria is generally likely to be extremely low immediately after a donation of blood despite concentrations > 10 9 bacteria per ml being ultimately detected in transfusion incidents. According to model experiments with inoculated RBC concentrates, 1-10 bacteria per ml are sufficient to start this type of growth. However, determination of the initial concentrations of bacteria in actual blood donations has never been carried out to date. The assumption that very low concentrations are present initially is also supported by the observation that no bacteria were detected in sections of tubes disconnected immediately after donation of RBC concentrates that were contaminated with Yersinia bacteria (10 7 -10 9 CFU/ml) and led to severe incidents [28] . There are no practical procedures for routine monitoring of blood donations as is standard practice for viral markers. The sterility testing used by blood donation services is based on random samples and is solely intended to satisfy the need for information about the quality of the stored blood and occasionally that of the donor. It is not suitable for detecting infected blood samples. The initial bacterial concentration of these samples is suspected to be extremely low and would probably frequently be below the limit of detection in sterility tests and NATs. Accordingly, a test can only be employed successfully after the bacteria had grown (e.g. before distribution of the blood product). However, this procedure would lead to unacceptable delays in the distribution of blood products at present as the culturing methods and NATs take too long. In addition, these tests would necessitate opening the bag, an action that is associated with a risk of contamination and has to be avoided at all costs. As mentioned above, tube sections with a volume of 300 to 500 µl are not suitable for this procedure. Regardless of the clinical experience, with the concentrations suspected to be as low as 1-10 bacteria per ml, the sections are likely to be evaluated as being free from pathogens simply for statistical reasons. Results have been reported for less complex procedures than the determination of bacterial growth -for example, the use of PCR for Y. enterocolitica [29] ; however, these are not suitable for routine use. Other direct determination procedures such as Gram's staining, acridine orange staining and universal gene probes for bacterial rRNA are regarded as being too insensitive or impractical [21] . Various procedures with an indirect approach (surrogate tests) have been suggested, such as the determination of pH value changes or decreased glucose contents. These procedures would involve relatively little time and technical expenditure. Urine dipsticks showed lowered pH and glucose values in artificially inoculated platelet concentrates [30] . The Enterobacteriaceae tested included Klebsiella pneumoniae and Serratia marcescens but not Y. enterocolitica. The procedure is currently undergoing trials with platelet concentrates applied clinically. No reports have been made of an attempt to extend the method to RBC concentrates. The most reasonable approach would be to carry out the test immediately before the scheduled transfusion when the bag would be opened anyway and the concentration of the bacteria would be at a relevant level. The literature indicates that even blood products with highgrade contamination present a normal appearance. Only one case (with a fatal outcome) was reported in which haemolytically changed plasma was observed in the remainder left in the bag [28] . The frequently quoted signs of microbiological contamination such as a dark colour, formation of lumps and haemolysis or discolouration of the (acellular) supernatant can therefore not be relied upon if transfusion of blood products contaminated with Y. enterocolitica is to be avoided. However, this does not alter the obligation to scrupulously inspect stored blood for the above-mentioned signs before transfusion.
Methods for Removal and Inactivation of the Infectious Agent
One suggestion for a comprehensive measure against bacterial growth in blood bags involved adding antibiotics to the stored blood [31] . However, the expense involved and the risk of side-effects such as allergisation or an already existing allergy in the recipients and the promotion of resistance development have prevented this measure from being implemented. Experiments with platelet concentrates, which are very rarely contaminated with Y. enterocolitica, have shown that in principle it is possible to kill these (and other) pathogens in blood components. Treatment with a psoralen (S-59) followed by UV radiation (UVA, 320-400 nm) achieved a reduction of Y. enterocolitica by a factor of 10 6 [32] . No such experiments have been carried out for the typically affected RBC. Indeed, it must first be clarified whether this kind of treatment damages RBC concentrates and is toxicologically safe. In addition, the light permeability of these blood components in the bags currently used is insufficient. Various experimental studies have investigated whether Y. enterocolitica can be eliminated by white blood cell (WBC) filtration. In general, a significant reduction ranging up to elimination of the bacteria has been reported (depending on the serotype). However, the vast majority of these studies included methodological shortcomings (e.g. failure to detect antibodies against Y. enterocolitica, failure to consider any loss of virulence plasmids during laboratory culturing, failure to distinguish between the different serotypes), and their findings must be interpreted in the light of these shortcomings. However, a summarising evaluation of all experimental data rather indicates that a time-dependent reduction in the number of Y. enterocolitica capable of multiplying can be achieved by storing the (whole blood) donation at room temperature (see also 1.1). This evaluation of the findings was connected with the idea that the bacteria, being facultative and intracellular, survive primarily in phagocytes (monocytes, granulocytes) or are simply associated with them, and therefore that WBC depletion leads to bacterial reduction. Storage itself allows the bactericidal elements of plasma to take effect (see below and the detailed description in [33] ). The literature does not contain specific information on the ideal storage time for whole blood before WBC filtration. Buchholz et al. [9] worked with a retention time of 7 h at room temperature in their experimental studies with Y. enterocolitica O:3. Under these conditions, they were able to demonstrate complete sterility in all samples after WBC filtration, with the exception of the sample with the highest pathogen contamination (132 CFU/ml). The significance of the complement in the destruction of Y. enterocolitica in whole blood donations and RBC concentrates was investigated by Gibb et al. [25] . Using precisely defined strains, they demonstrated that Y. enterocolitica susceptible to the complement could no longer be eliminated reliably by the complement at plasma concentrations below 26%. They concluded from their findings that the plasma dilution brought about by component separation must not take place until after 6 h of storage at room temperature at the earliest in order to ensure that all extracellular bacteria are eliminated. The experimental findings of Buchholz et al. [9] and Gibb et al. [25] provide sufficient grounds for recommending that donated blood be stored unfractionated for at least 6 h at room temperature before it is separated into its components.
Feasibility and Validation of Procedures for Removal/ Inactivation of the Infectious Agent
While Y. enterocolitica can considerably compromise the safety of blood components, it has no effect on plasma-derived substances. RBC concentrates are typically affected; platelet concentrates are affected in exceptional cases. No reports are available on incidents with fresh frozen plasma. There are no standard procedures in practice yet for eliminating or inactivating bacteria or, in this case, Yersinia bacteria from cellular blood products. It may be possible to eliminate any Yersinia bacteria present using WBC filtration, which is currently promoted for eliminating intracellular viruses and the Creutzfeldt-Jakob agent. It remains unclear whether the conditions that seem ideal for separation of some species of bacteria, in particular Yersinia bacteria, are compatible with the other requirements for processing whole blood donations. An extended period of observation is necessary to determine whether WBC depletion actually represents a real improvement. The small case numbers observed to date do not permit a short-term evaluation.
Assessment
Transfusion incidents arising from Y. enterocolitica are rare; the total rate of transfusion reactions caused by Y. enterocolitica is placed at 1:500,000. A frequency of between 1:1,000,000 and 1:10,000,000 for fatal incidents is reported in the literature. However, it must be noted in regard to these figures that systematic registration of bacterial transfusion incidents has been neglected to date. More data should be provided by current studies, e.g. the Bacony Study of the Centers for Disease Control currently underway in the USA or the haemovigilance records of the Agence Française du Sangue. In the event of transfusion reactions, it is vital that the possibility of an infection with Y. enterocolitica is considered, that diagnostic steps are implemented as required and that the incident is reported. Consideration of the potential prophylactic measures in discussion since the late 1980s is complicated by the low case incidence and the poor quality of basic data on the current status. These circumstances add to the difficulties involved in carrying out adequate cost/benefit analyses, in particular in regard to any measures designed solely to tackle Yersinia bacteria. Suggestions have included the exclusion of donors who have suffered feverish disorders and/or diarrhoea during the previous 4 weeks. Current data from Germany suggest that this measure would not significantly increase the rejection rate for blood donations. The scanty nature of the available data means that it is impossible to determine whether questioning donors in this manner would lead to a decrease in the number of transfusion reactions attributable to Y. enterocolitica. Nonetheless, a reduction in contaminations caused by Y. enterocolitica and other bacterial pathogens would be likely. We therefore recommend that a question concerning feverish disorders and/or diarrhoea is added to the donor selection criteria. Many aspects argue in favour of WBC filtration if it is carried out after sufficient preliminary incubation of the unfractionated blood donation at room temperature. WBC filtration has now been introduced in many European countries for different reasons; in other countries, including Germany, introduction of this measure is being considered. This development should be exploited, and attempts should be made to include measures to eliminate Yersinia bacteria in the general procedure for WBC filtration (i.e. storage of whole blood for at least 6 h at room temperature before WBC filtration).
